FDMT
$19.52
4D Molecular Therapeutics
$1.25
6.84%
FDMT
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus: ($0.77)
Revenue: $0.96 Mil
Latest EPS
Wednesday, May 10, 2023
What do you expect when FDMT reports earnings?
Where is FDMT's stock price going from here?
Analysts
Pivots
Resistance
$22.78
$21.97
$20.75
Support
$18.72
$17.91
$16.69
Description
4D Molecular Therapeutics Inc. is a clinical-stage gene therapy company which develops product candidates using its targeted and evolved adeno-associated viruses vectors. It offers a portfolio of gene therapy product candidates focusing on the ophthalmology, cardiology and pulmonology therapeutic areas. 4D Molecular Therapeutics Inc. is based in Emeryville, California.
